Recent revelations regarding a potential rare side effect of AstraZeneca's COVID-19 vaccine, Covishield, have sparked concerns among the public. A legal submission by AstraZeneca admitted that their vaccine could lead to Thrombosis with Thrombocytopenia Syndrome (TTS), a condition characterised by blood clot formation and low platelet count. However, it's important to understand the actual risk associated with this side effect.Image: IANS . Thrombosis with Thrombocytopenia Syndrome (TTS) is a... Read this story